AlzTEST®
Alzheimer's Disease Diagnosis
Not SpecifiedActive
Key Facts
About Neuron Biopharma
Neuron Biopharma operates a dual business model spanning diagnostics and industrial biotechnology. Its pharmaceutical division, Neuron Biolabs, focuses on diagnostic tools like AlzTEST® for Alzheimer's, while its industrial biotech arm, Neol Bio, develops microbial fermentation processes for products such as Omega-3 DHA. The company is publicly traded but has faced significant financial challenges, including a creditor bankruptcy proceeding initiated in 2017. Its strategy leverages biotech platforms to address needs in both healthcare and sustainable industrial production.
View full company profileTherapeutic Areas
Other Alzheimer's Disease Diagnosis Drugs
| Drug | Company | Phase |
|---|---|---|
| iRS-AD | BetaSense | Research/Development |
| Afina Retinal Imaging | NeuroVision Imaging | Validation/Development |
| Aβ1-40/Aβ1-42/Tau IMR Reagents | MagQu | Commercial |
| Alzheimer's Biomarker | Aelan Cell Technologies | Test Stage |
| Oligomer Diagnostic Biomarkers | Abyssinia Biologics | Preclinical/Research |
| ABtest-Service | Araclon Biotech | Commercial |